title: The ELITE study. Evaluation of Losartan in the Elderly Study.
authors.forename: P
authors.initials: P
authors.lastname: Shiels
authors.forename: A
authors.initials: A
authors.lastname: Naas
authors.forename: P
authors.initials: P
authors.lastname: Lim
authors.forename: A
authors.initials: A
authors.lastname: Leary
authors.forename: T
authors.initials: T
authors.lastname: MacDonald
mesh_terms: D000328:Adult; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000494:pharmacology*; D002216:Captopril / Q000494:pharmacology; D003401:Creatine / Q000097:blood; D018592:Cross-Over Studies; D004562:Electrocardiography; D006321:Heart / Q000187:drug effects / Q000502:physiology; D006801:Humans; D019808:Losartan / Q000494:pharmacology; D008297:Male; D013777:Tetrazoles / Q000494:pharmacology*; D014633:Valine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000068756:Valsartan
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D013777:Tetrazoles; D000068756:Valsartan; D002216:Captopril; D014633:Valine; D019808:Losartan; D003401:Creatine